Alivus Life Sciences Ltd.
BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
1037.50
32.10 (3.19%) Alivus Life Sciences informs about media release
Date: 18-01-2025Alivus Life Sciences has informed that it attached media release titled ‘Glenmark Life Sciences rebrands as Alivus Life Sciences’.
The above information is a part of company’s filings submitted to BSE.